David Dubin on When to Look for Lynch Syndrome
Dave Dubin, founder of AliveAndKickn, discusses the importance of healthcare professionals knowing when to test for Lynch syndrome.
Dave Dubin, founder of AliveAndKickn, discusses the importance of healthcare professionals knowing when to test for Lynch syndrome.
One of the goals of AliveAndKickn is to educate clinicians about when to test for Lynch syndrome. They should know that Lynch syndrome could cause a variety of cancers at any given time, and perhaps a patient coming in with colon cancer should not only be treated solely for the specific tumor type, but also be tested, if appropriate, for the genetic mutation.
Nivolumab/Chemo Improves Survival in Advanced Gastric/GEJ Cancer
March 14th 2024The use of nivolumab plus chemotherapy as a standard frontline treatment has been supported by recent data from the phase 3 CheckMate 649 trial for patients with gastric, gastroesophageal junction, and esophageal adenocarcinoma.
